Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Leggett currently holds 44,250 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Leggett has been a net seller of BDTX stock. They have purchased $0 and sold $495.6K worth of shares.
Thomas Leggett's most recent insider trade was on Mar 15, 2026, when they sold 14,750 shares at $0.00 per share.
Thomas Leggett serves as Executive at Black Diamond Therapeutics, Inc. (BDTX). They have executed 14 insider transactions totaling $495.6K over their tenure at the company.
Thomas Leggett holds the position of Executive at Black Diamond Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Thomas Leggett has shown a selling trading pattern, with $0 in total purchases and $495.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Leggett was on Jan 8, 2021, when they sold $101.8K worth of BDTX shares. This transaction involved 3,000 shares at $33.94 per share.
Thomas Leggett currently owns 44,250 shares of Black Diamond Therapeutics, Inc. (BDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Leggett's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Leggett has 14 Form 4 filings on record as an insider at Black Diamond Therapeutics, Inc..
Set alerts for Thomas Leggett and 40,000+ other insiders.